Article
Novel envelope determinants for CCR3 use by human immunodeficiency virus.
Journal of virology - 1 Nov 2006
Aasa-Chapman Marlén M I, Seymour Craig R, Williams Ian, McKnight Aine
Abstract excerpt
Human immunodeficiency virus type 1 can generally use CCR3 and CCR5 for cell entry. We show that envelopes with novel phenotypes arise during "coreceptor switch": one loses the ability to use CCR3 (R5-only phenotype), and another gains use of CXCR4 in addition to CCR5 and CCR3 (R3/R5/X4-using phenotype). The envelope determinants for CCR3 use mapped to three amino acids. One, N356 in conserved region 3, is a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
